S Chawla1, Y Ge2, H Lu3, O Marshall1, M S Davitz1, G Fatterpekar1, B J Soher4, O Gonen2. 1. From the Department of Radiology (S.C., Y.G., O.M., M.S.D., G.F., O.G.), Center for Advanced Imaging Innovation and Research and Bernard and Irene Schwartz Center for Biomedical Imaging, New York University School of Medicine, New York, New York. 2. From the Department of Radiology (S.C., Y.G., O.M., M.S.D., G.F., O.G.), Center for Advanced Imaging Innovation and Research and Bernard and Irene Schwartz Center for Biomedical Imaging, New York University School of Medicine, New York, New York yulin.ge@nyumc.org oded.gonen@nyumc.org. 3. The Russell H. Morgan Department of Radiology and Radiological Science (H.L.), Johns Hopkins University School of Medicine, Baltimore, Maryland. 4. Department of Radiology (B.J.S.), Center for Advanced MR Development, Duke University Medical Center, Durham, North Carolina.
Abstract
BACKGROUND AND PURPOSE: Although NAA is often used as a marker of neuronal health and integrity in neurologic disorders, its normal response to physiologic challenge is not well-established and its changes are almost always attributed exclusively to brain pathology. The purpose of this study was to test the hypothesis that the neuronal cell marker NAA, often used to assess neuronal health and integrity in neurologic disorders, is not confounded by (possibly transient) physiologic changes. Therefore, its decline, when observed by using (1)H-MR spectroscopy, can almost always be attributed exclusively to brain pathology. MATERIALS AND METHODS: Twelve healthy young male adults underwent a transient hypercapnia challenge (breathing 5% CO2 air mixture), a potent vasodilator known to cause a substantial increase in CBF and venous oxygenation. We evaluated their whole-brain NAA by using nonlocalizing proton MR spectroscopy, venous oxygenation with T2-relaxation under spin-tagging MR imaging, CBF with pseudocontinuous arterial spin-labeling, and the cerebral metabolic rate of oxygen, during normocapnia (breathing room air) and hypercapnia. RESULTS: There was insignificant whole-brain NAA change (P = .88) from normocapnia to hypercapnia and back to normocapnia in this cohort, as opposed to highly significant increases: 28.0 ± 10.3% in venous oxygenation and 49.7 ± 16.6% in global CBF (P < 10(-4)); and a 6.4 ± 10.9% decrease in the global cerebral metabolic rate of oxygen (P = .04). CONCLUSIONS: Stable whole-brain NAA during normocapnia and hypercapnia, despite significant global CBF and cerebral metabolic rate of oxygen changes, supports the hypothesis that global NAA changes are insensitive to transient physiology. Therefore, when observed, they most likely reflect underlying pathology resulting from neuronal cell integrity/viability changes, instead of a response to physiologic changes.
BACKGROUND AND PURPOSE: Although NAA is often used as a marker of neuronal health and integrity in neurologic disorders, its normal response to physiologic challenge is not well-established and its changes are almost always attributed exclusively to brain pathology. The purpose of this study was to test the hypothesis that the neuronal cell marker NAA, often used to assess neuronal health and integrity in neurologic disorders, is not confounded by (possibly transient) physiologic changes. Therefore, its decline, when observed by using (1)H-MR spectroscopy, can almost always be attributed exclusively to brain pathology. MATERIALS AND METHODS: Twelve healthy young male adults underwent a transient hypercapnia challenge (breathing 5% CO2 air mixture), a potent vasodilator known to cause a substantial increase in CBF and venous oxygenation. We evaluated their whole-brain NAA by using nonlocalizing proton MR spectroscopy, venous oxygenation with T2-relaxation under spin-tagging MR imaging, CBF with pseudocontinuous arterial spin-labeling, and the cerebral metabolic rate of oxygen, during normocapnia (breathing room air) and hypercapnia. RESULTS: There was insignificant whole-brain NAA change (P = .88) from normocapnia to hypercapnia and back to normocapnia in this cohort, as opposed to highly significant increases: 28.0 ± 10.3% in venous oxygenation and 49.7 ± 16.6% in global CBF (P < 10(-4)); and a 6.4 ± 10.9% decrease in the global cerebral metabolic rate of oxygen (P = .04). CONCLUSIONS: Stable whole-brain NAA during normocapnia and hypercapnia, despite significant global CBF and cerebral metabolic rate of oxygen changes, supports the hypothesis that global NAA changes are insensitive to transient physiology. Therefore, when observed, they most likely reflect underlying pathology resulting from neuronal cell integrity/viability changes, instead of a response to physiologic changes.
Authors: Clarisse I Mark; Marat Slessarev; Shoji Ito; Jay Han; Joseph A Fisher; G Bruce Pike Journal: Magn Reson Med Date: 2010-09 Impact factor: 4.668
Authors: Robert M Douglas; Julie Ryu; Amjad Kanaan; Maria Del Carmen Rivero; Laura L Dugan; Gabriel G Haddad; Sameh S Ali Journal: Am J Physiol Cell Physiol Date: 2010-03-31 Impact factor: 4.249
Authors: Sina Aslan; Feng Xu; Peiying L Wang; Jinsoo Uh; Uma S Yezhuvath; Matthias van Osch; Hanzhang Lu Journal: Magn Reson Med Date: 2010-03 Impact factor: 4.668
Authors: Feng Xu; Jinsoo Uh; Matthew R Brier; John Hart; Uma S Yezhuvath; Hong Gu; Yihong Yang; Hanzhang Lu Journal: J Cereb Blood Flow Metab Date: 2010-09-15 Impact factor: 6.200
Authors: J M Pollock; A R Deibler; C T Whitlow; H Tan; R A Kraft; J H Burdette; J A Maldjian Journal: AJNR Am J Neuroradiol Date: 2008-10-14 Impact factor: 3.825